Information for
Researchers
Table 1. Baseline characteristics early data release (n=739). Click here for a pdf.
|
Characteristics
|
Mean [range]
|
|
Age
|
64 [19-89]
|
|
Frequency (%)
|
|
Sex
|
|
|
Men
|
549 (74%)
|
|
Women
|
190 (26%)
|
|
Tumor location
|
|
|
Oral cavity
|
199 (27%)
|
|
Oropharynx
|
263 (35%)
|
|
Hypopharynx
|
52 (7%)
|
|
Larynx
|
205 (28%)
|
|
Unknown primary
|
20 (3%)
|
|
Disease stadium*
|
|
|
I
|
157 (21%)
|
|
II
|
126 (17%)
|
|
III
|
139 (19%)
|
|
IV
|
317 (43%)
|
|
Treatment
|
|
|
Single treatment
|
394 (53%)
|
|
Surgery
|
153 (39%)
|
|
Among which CO2-laser
|
47 (31%)
|
|
Radiotherapy
|
241 (61%)
|
|
|
|
|
Combination treatment
|
345 (47%)
|
|
Chemoradiotherapy
|
213 (62%)
|
|
Surgery and radiotherapy
|
107 (31%)
|
|
Surgery and chemoradiotherapy
|
24 (7%)
|
|
Other combination treatment**
|
1 (0.3%)
|
* Stadium was based on clinical TNM (cTNM) or if available, pathological TNM (pTNM)
** Other combination treatment was radiotherapy with hyperthermic treatment
